Rapport Therapeutics, Inc. Common Stock (RAPP) vs Syndax Pharmaceuticals, Inc. (SNDX)
A side-by-side comparison of Rapport Therapeutics, Inc. Common Stock and Syndax Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RAPP
Rapport Therapeutics, Inc. Common Stock
$31.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SNDX
Syndax Pharmaceuticals, Inc.
$17.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RAPP vs SNDX
growth of $100 · dividends reinvested · last 2yRAPP +54.8% (+24.4%/yr)SNDX -7.2% (-3.7%/yr)RAPP compounded faster over this window
RAPP SNDX
RAPP vs SNDX: by the numbers
- •SNDX is the larger company ($1.54B vs $1.49B market cap).
- •Both run net losses; SNDX's is the smaller (-87.60% vs -685.80% net margin).
Metrics side by side
Valuation
| Metric | RAPP | SNDX |
|---|---|---|
| P/S ratio | 74.49 | 6.11 |
| P/B ratio | 3.52 | 101.94 |
Profitability
| Metric | RAPP | SNDX |
|---|---|---|
| Gross margin | 0.00% | 97.47% |
| Operating margin | 0.00% | -158.45% |
| Net margin | -685.80% | -87.60% |
| ROE | -32.43% | -1462.12% |
| ROIC | -35.66% | -32.15% |
Growth (annualized)
| Metric | RAPP | SNDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 178.06% |
| Total return CAGR (5Y) | N/A | -0.01% |
Go deeper
Dig into the metrics
Rapport Therapeutics, Inc. Common Stock ROESyndax Pharmaceuticals ROERapport Therapeutics, Inc. Common Stock operating marginSyndax Pharmaceuticals operating marginRapport Therapeutics, Inc. Common Stock revenue growthSyndax Pharmaceuticals revenue growthRapport Therapeutics, Inc. Common Stock free cash flowSyndax Pharmaceuticals free cash flow
Rapport Therapeutics, Inc. Common Stock & Syndax Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.